NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pulmicort Respules on Relapse Rates After Treatment in the ED
Pulmicort Respules on Relapse Rates After Treatment in the ED

NCT00584636

WithdrawnPhase 4

Sponsor: Phoenix Children's Hospital

Conditions: Asthma

Interventions: pulmicort respules

Countries: United States

The purpose of this study is to see if the addition of budesonide to oral corticosteroids will result in a decrease in relapse rates compared to oral corticosteroids alone in children who are discharged from the ED after an asthma exacerbation. Secondly, that there will be an improvement in lung function, a decrease in beta-2 agonist use and an improvement in health-related quality of life compared to placebo.

Eligibility overview

Sex: ALL

Age: 2 Years to 8 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

Patient is between the ages of 2 and 8

* Has previously been diagnosed with asthma by any physician
* Has presented to the ED with an asthma exacerbation judged by a physician that is believed would not required admission to the hospital

Exclusion Criteria:

* Children less than 2 years (wheezing may be due to bronchiolitis)
* Children who have been on oral or inhaled corticosteroid in the last week, are pregnant, or unavailable for follow-up
* Pregnant
* Has chronic lung diseases (i.e. cystic fibrosis)
Locations (1)
  • Phoenix, Arizona, United States